Filing Details
- Accession Number:
- 0000898432-20-000499
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-14 19:57:19
- Reporting Period:
- 2020-04-09
- Accepted Time:
- 2020-04-14 19:57:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1325618 | Iradimed Corp | IRMD | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1254747 | Brent Johnson | C/O Iradimed Corporation 1025 Willa Springs Dr. Winter Springs FL 32708 | Exec. Vp Of Ww Sales And Mktg | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-09 | 4,000 | $1.48 | 6,940 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-09 | 4,000 | $20.11 | 2,940 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-04-10 | 2,065 | $0.00 | 5,005 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-10 | 1,342 | $19.99 | 3,663 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-04-09 | 4,000 | $0.00 | 4,000 | $1.48 |
| Common Stock | Restricted Stock Units | Disposition | 2020-04-10 | 2,065 | $0.00 | 2,065 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 114,474 | 2023-12-31 | No | 4 | M | Direct | |
| 0 | No | 4 | M | Direct |
Footnotes
- The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.
- This transaction was executed in multiple trades at prices ranging from $20.00 to $20.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Restricted stock units convert into common stock on a one-for-one basis.
- On December 14, 2016, December 4, 2017, and December 7, 2018 the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 14, 2017, December 4, 2018 and December 7, 2019 respectively. The scheduled vestings were accelerated by the registrant, and the restricted stock units became vested as of April 10, 2020. Upon vesting, the reporting person received a number of shares of common stock equal to the number of restricted stock units that vested.
- This option, representing a right to purchase a total of 199,759 shares, was granted on December 31, 2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. 49,939 shares from this award were previously exercised in December 2015.
Billionaire Hedge Funds
